Gillian Fenton

Job Title: Special Counsel
Company: GSK

Gillian M. Fenton, Esq., CLP has been a member of LES (USA & Canada) since 1992, and served as the society President in 2020-2021.  She is presently a member of the society Public Policy Committee.

Gillian is also Special Counsel for Innovation and Government Collaborations at GSK Vaccines.  Her practice includes a wide variety of business development transactions, R&D collaborations and nondilutive funding agreements with U.S. Government entities (NIH/NIAID, BARDA and DARPA), all in support of the vaccines pipeline.  Prior to joining GSK, Gillian was VP, Associate General Counsel & Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and supported all IP aspects of the company‚Äôs IPO and subsequent 9 years of growth through M&A in the vaccines, biodefense, and global health fields. 

Education: J.D. cum laude, Suffolk University Law School; B.Sc. Biochemistry, Trinity College.

Admissions: MA, MD, DC.  Registered U.S. Patent Attorney.